Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medinotec (MDNC) EBIT Margin (2022 - 2025)

Medinotec filings provide 4 years of EBIT Margin readings, the most recent being 21.79% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 122.0% to 21.79% in Q4 2025 year-over-year; TTM through Nov 2025 was 29.02%, a 1024.0% increase, with the full-year FY2025 number at 35.02%, up 2306.0% from a year prior.
  • EBIT Margin hit 21.79% in Q4 2025 for Medinotec, up from 16.33% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 55.58% in Q1 2025 to a low of 127.02% in Q3 2022.
  • Median EBIT Margin over the past 4 years was 12.94% (2023), compared with a mean of 1.85%.
  • Biggest five-year swings in EBIT Margin: skyrocketed 14290bps in 2023 and later plummeted -850bps in 2025.
  • Medinotec's EBIT Margin stood at 6.57% in 2022, then skyrocketed by 96bps to 12.88% in 2023, then soared by 60bps to 20.56% in 2024, then increased by 6bps to 21.79% in 2025.
  • The last three reported values for EBIT Margin were 21.79% (Q4 2025), 16.33% (Q3 2025), and 13.0% (Q2 2025) per Business Quant data.